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Abstract: Attention deﬁ  cit hyperactivity disorder (ADHD) is treated with stimulants and 
psycho-educational remedial programs despite limited literature support for the latter. This 
study aimed to examine changes in a “Test of Visual Perceptual Skills” (TVPS) that has not 
been previously reported in children with ADHD enrolled in such a program.
Methods: Sixteen children, 7–11 years old, with ADHD were involved in occupational therapy 
and special education geared towards attention training. Six months later methylphenidate 
1 mg/kg/day was prescribed. It was not taken by eight children because of family choice. The 
TVPS was given twice, upon diagnosis, and 8 months post-intervention. The groups were 
compared by a repeated measures analysis of variance (ANOVA) with medication as a between 
groups factor and test-retest scores as within factor.
Results: All children demonstrated increases in total scores in the second measurement. 
Medicated children scored higher but ANOVA showed a nonsigniﬁ  cant F for the two groups, 
medicated and unmedicated (F = 0.0031, p = 0.9563), indicating a nondifferential effect of the 
two levels of treatment. It revealed a signiﬁ  cant F for the pre- and post-treatment total TVPS 
scores (F = 30.91, p  0.0001) indicating a signiﬁ  cant difference between pre- and post-treatment 
tests. The interaction between pre-post treatment and level of treatment (medicated–unmedicated) 
was nonsigniﬁ  cant (F = 2.20, p = 0.1604).
Conclusion: TVPS scores improved in all children following intervention. Medicated children 
did better, but differences were nonsigniﬁ  cant.
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Introduction
Attention deﬁ  cit hyperactivity disorder (ADHD) is one of the most frequent chronic 
conditions of childhood, occurring in 4%–12% of school age children (AAP 2001); 
it has a signiﬁ  cant impact on child mental health and education. Accurate diagnosis, 
measurement of impairment, and monitoring of symptoms overtime are important for 
successful management. The treatment of ADHD includes stimulants and/or psycho-
educational interventions. Stimulants are effective in controlling ADHD core symptoms 
in 70%–80% of the patients; these are considered the safest of all the medications 
utilized in this condition (Olfson et al 2003). The evidence supporting medication-
based interventions is strong; consensus treatment algorithms to guide the multimodal 
treatment of ADHD, alone and in combination with common co-morbidities, have 
been discussed (Remschmidt 2005). Methylphenidate, the most frequently used 
stimulant, gives better motivation and drive than the others making patients work more 
intensely; the duration of its effect is short, but the breadth of its impact is impres-
sive (Conners 2002). Treatment with stimulants is more effective in the reduction of Neuropsychiatric Disease and Treatment 2007:3(6) 950
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ADHD symptoms than an intensive program of behavioral 
and cognitive intervention; the combination of stimulants 
with psychosocial interventions offers few advantages over 
medication alone (Santosh and Taylor 2000). The Multi-
modal Treatment Study concluded that careful medication 
management with good follow-up is more effective than 
intensive behavioral treatment (The MTA cooperative group 
1999); combination of medication and intensive behavioral 
treatment was also signiﬁ  cantly superior to psychosocial 
treatments alone in reducing ADHD symptoms. Neverthe-
less, many societies and child health specialists prefer to rely 
on psycho-educational interventions such as occupational 
therapy, special education, and psychotherapy, rather than 
stimulants, despite the cost and the time investment involved 
(Nianiou et al 2003). The literature provides little support for 
expanded psycho-educational treatment options and stresses 
the need for well-designed rigorous studies (AAP 2001). 
Neuropsychological evaluation of children with ADHD is 
often requested on diagnosis along with behavioral rating 
scales for parents and teachers (Biederman et al 2004). How-
ever, measuring progress of children involved in treatment 
is not routinely done. The reason for this could be related to 
assessment difﬁ  culties; lengthy testing sessions are counter-
productive because attention problems interfere with the 
process and create difﬁ  culties in the interpretation of incorrect 
results. Testing for treatment response in individual children 
with ADHD has not been adequately evaluated (Mollica et al 
2004). The clinical effectiveness of stimulant medications 
is no longer in doubt but the efﬁ  cacy of psycho-educational 
interventions and the patterns of changes in ADHD need 
to be explored. Perceptual and spatial disorders have been 
much less investigated than other domains. Visual perception 
is the capacity to interpret or give meaning to what is seen; 
it includes recognition, insight and interpretation of what 
is seen, at the higher levels of the central nervous system 
(Buktenica 1968). Visual perceptual skills have not been 
studied in children with ADHD. They have been investigated 
in children with reading problems and have been found to 
probably contribute to them (Grifﬁ  n et al 1993) as well as 
in children with cerebral palsy (Menken et al 1987; Stiers 
et al 2002).
The objective of this investigation was to examine 
changes in a TVPS that has not been previously utilized 
in children with ADHD, before and after intervention with 
individualized psycho-educational training and stimulants. 
We hypothesized that all children were going to have sig-




Sixteen children, 13 boys and 3 girls, 7–11 years of age 
(mean age 8 years and 3 months) were enrolled in the study. 
The patients were included on the basis of fulﬁ  lling DSM-IV 
ADHD diagnostic criteria (APA 1994) and being students of 
regular schools. They were all considered good candidates 
for stimulant medication. Comorbidity with other conditions 
commonly seen in children with ADHD, resource class, or 
other type of tutoring within the school system were not 
exclusion criteria. According to our treatment protocol for 
children with ADHD, all of them were referred for compre-
hensive psycho-educational testing and intervention prior to 
the initiation of stimulant treatment. After the testing was 
completed they became involved in a 5-hour/week remedial 
program of occupational therapy and special education that 
was carried out by the same team of occupational therapists, 
special educators, and clinical psychologists. The psycho-
educational training was individually tailored to each child’s 
needs and ﬂ  exible enough to accommodate for changes. 
Occupational therapy was geared towards attention training; 
it was based on therapeutic principles of motor-perceptual 
training, cognitive-perceptual training, and sensory integra-
tion. Special education included psycho-paedagogic sessions 
based on behavioral techniques; additionally, an educational 
program in accordance to the grade level of the child was 
followed. After 6 months of psycho-educational activities 
methylphenidate was prescribed at a dose of 1 mg/kg/day, 
divided in 3 daily doses, to be given at 8 am, 12 noon, and 
4 pm. Eight children (6 boys and 2 girls, mean age 7 years 
and 11 months) took the medication as prescribed and 8 
(7 boys and 1 girl, mean age 8 years and 6 months) did not, 
because the families chose not to proceed with medication 
due to their own fears and beliefs regarding stimulant use. 
All children regardless of medication status continued the 
psycho-educational intervention.
Measures
The TVPS (nonmotor) Revised (TVPS-R) was utilized 
(Gardner 1996). This test consists of seven subtests: 1. 
Visual discrimination, which refers to a subject’s ability to 
match or determine exact characteristics of two forms when 
one of the forms is among similar forms. 2. Visual memory, 
which refers to a subject’s ability to remember for immedi-
ate recall (after 4–5 seconds) all of the characteristics of a 
given form, and being able to ﬁ  nd this form from an array of 
similar forms. 3. Visual spatial-relationships, which refers to 
a subject’s ability to determine the correct direction of forms Neuropsychiatric Disease and Treatment 2007:3(6) 951
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(spatial relations). 4. Visual form-constancy, which refers to a 
subject’s ability to see a form, and being able to ﬁ  nd it, even 
though the form is rotated, reversed, or hidden among others. 
5. Visual sequential-memory, which refers to a subject’s ability 
to remember a number of forms in a series. 6. Visual ﬁ  gure-
ground, which refers to a subject’s ability to perceive a form 
visually, and to ﬁ  nd this form hidden in a conglomerated 
ground of matter. 7. Visual closure, which refers to a subject’s 
ability to determine, from among 4 incomplete forms, the one 
that would be the same as the completed one.
TVPS-R measures to what extent a subject (4–13 years) 
can perform in the above subtests. Directions require a mini-
mum amount of language and can be given in any language. 
In fact it is described as a test nonbiased for culture, gender, 
and education. From the original raw scores determined 
for each subtest the following derived scores are obtained: 
Standard scores for each age level, percentile ranks, and per-
ceptual ages. These derived scores allow comparisons of the 
subjects’ performance to that of normal children of the same 
age-group. The test was given twice; ﬁ  rst, upon diagnosis and 
prior to any intervention and subsequently, eight months after 
occupational therapy and special education were initiated. In 
the medicated group the test was carried out one hour after 
methylphenidate administration.
Statistical analysis
In our study we had two experimental conditions (medicated 
and nonmedicated children) and different subjects have 
been used in each condition. In order to compare the mean 
total scores, an analysis of variance has been performed. 
Because we had a pre-treatment and a post-treatment test 
and one experimental condition with two levels (medicated 
and nonmedicated) we performed a two-way analysis of 
variance (mixed model) with one between variable having 
two levels (a. education plus medication and b. education 
without medication) and one within variable also having two 
levels (a. pre-treatment test and b. post-treatment test). The 
dependent variable was the total TVPS scores which was 
composed of 7 sub-scores.
Results
In Table 1 the age, sex, ADHD type, co-morbidity, and 
medication status of the children are listed. The comprehen-
sive psycho-educational testing that preceded the remedial 
treatment program revealed that in addition to the ADHD, 
four children had borderline intelligence, six were dyspraxic, 
and three dysgraphic. Three children did not demonstrate 
associated co-morbidity.
After all data were collected and the standard scores 
were obtained, we performed descriptive statistics on each 
variable. Table 2 indicates the means, standard deviations, 
and ranges of the total and sub-category scores in both 
tests, in medicated and nonmedicated patients. As we can 
see, both medicated and nonmedicated children appear to 
have an increase in their score means in the second time of 
measurement with the exception of closure category in the 
nonmedicated group where a small decrease was noticed 
(from mean 5.375 ± 3.02 to mean 4.25 ± 3.732).
Subsequently, in order to compare all groups a 2X2 mixed 
analysis of variance was performed with medication as a 
between groups factor and test- retest scores as within factor. 
At ﬁ  rst, a t-test was performed for the purpose of detecting 
any differences between the total TVPS scores of the two 
groups (medicated and nonmedicated) in the pre-treatment 
condition. The t-test value was nonsigniﬁ  cant (t = 0.0031, 
p = 0.741), indicating that the two groups (medicated and 
nonmedicated) were equivalent. The analysis of variance 
(Table 3) resulted in a nonsigniﬁ  cant F for the two groups, 
medicated and nonmedicated (F = 0.0031, p = 0.9563), indi-
cating that there was no differential effect of the two levels 
of treatment. Furthermore, the analysis of variance revealed 
a signiﬁ  cant F for the pre-treatment and the post-treatment 
total TVPS scores (F = 30.91, p  0.0001) indicating that 
there was a signiﬁ  cant difference between the pre-treatment 
and the post-treatment tests. The interaction between pre-post 
treatment and level of treatment (medicated – nonmedicated) 
was nonsigniﬁ  cant (F = 2.20, p = 0.1604). As we can observe 
from the mean values on Table 2; both groups (medicated 
and nonmedicated) started with an equivalent total score on 
TVPS and, in the post-treatment test, both groups improved 
considerably, and the medicated children did better. The 
sample was smaller than required in order to allow for analy-
sis of the subcategory scores.
Discussion
The ﬁ  ndings of this study supported our initial hypothesis; 
all children enrolled in intervention had signiﬁ  cant changes 
in the TVPS total scores in the second time of measurement. 
This was noted irrespective of medication status with one 
exception in the score means in closure category in the non-
medicated group. These improvements were not merely the 
result of normal development because the analysis was done 
on standard scores for each age level that allowed comparisons 
of the subjects’ performance to that of normal children of the 
same age-group. The aim of this study was not to examine 
the effect of the stimulants versus that of the remedial program Neuropsychiatric Disease and Treatment 2007:3(6) 952
Papavasiliou et al
Table1 Age, sex,  ADHD type, co-morbidity, and medication status of the children
Patient number  Age (months)  Sex  ADHD type  Co-morbidity  Medication status
1 84  F  Combined  Dysgraphia  Methylphenidate
2 103  M  Combined  Borderline  Methylphenidate
       Intelligence
3 93  M  Combined  Borderline  Methylphenidate
       Intelligence
4 93  M  Combined  Dyspraxia  Methylphenidate
5 115  M  Combined    Methylphenidate
6 103  M  Combined  Dyspraxia  Methylphenidate
7 87  F  Combined  Dysgraphia  Methylphenidate
8 84  M  Combined    Methylphenidate
9 123  M  Combined    No
10 99  M  Combined  Dyspraxia  No
11 119  M  Combined  Dyspraxia  No
12 88  M  Combined  Dysgraphia  No
13 92  F  Combined  Borderline  No
       Intelligence
14 120  M  Combined  Dyspraxia  No
15 94  M  Combined  Dyspraxia  No
16 96  M  Combined  Borderline  No
       Intelligence
Abbreviation: ADHD, attention deﬁ  cit hyperactivity disorder.
and it was not anticipated that half of the subjects were going 
to be retested without medication. For this reason a control 
group was not included and retesting of the medicated children 
prior to stimulant onset was not planned. It was subsequently 
ascertained that medicated and nonmedicated children were 
not signiﬁ  cantly different at the outset through a t-test on the 
pretreatment TVPS scores. Comorbidity with other conditions 
commonly seen in children with ADHD was present in the 
majority of the subjects. It was not an exclusion criterion as 
this is very common, occurring in over 50% of patients; in 
fact, ADHD overlaps with other disorders at an extremely 
high rate (Gillberg 2003). Four patients were found to be of 
Table 2 Means, standard deviations, and ranges of the total and sub-category TVPS scores in tests in medicated and nonmedicated 
patients
 Pre-test  Post-test
 Medicated  Nonmedicated  Medicated  Nonmedicated
 Mean  ± SD  Mean ± SD  Mean ± SD  Mean ± SD
 (range)  (range)  (range)  (range)
Total 39.25  ± 21.829  43.125 ± 24.098  60.625 ± 25.690  55.5 ± 20.853
TVPS score  (12–72)  (7–71)  (30–105)  (15–87)
Discrimination 5.875  ± 4.086  7 ± 5.01  8.375 ± 5.370  9.5 ± 3.854
 (1–12)  (1–14)  (1–16)  (1–13)
Memory 5  ± 3.891  7.625 ± 4.479  9.875 ± 4.190  8 ± 4.175
 (1–13)  (1–13)  (2–15)  (2–14)
Spatial   6.375 ± 6.116  7. 25 ± 5.09  9 ± 7.091  10.25 ± 4.301
Relationships (1–17)  (1–13)  (1–18)  (1–14)
Form 5.5  ± 3.464  6 ± 3.464  8.375 ± 5.041  9.25 ± 2.964
Constancy (2–12)  (1–11)  (1–16)  (5–13)
Sequential 5.25  ± 4.097  5.6 ± 4.44  7.625 ± 4.34  6.25 ± 3.196
Memory (1–12)  (1–13)  (2–14)  (1–12)
Figure ground  7.25 ± 3.575  5.375 ± 4.406  10.125 ± 3.482  8 ± 3.817
 (1–11)  (1–14)  (5–16)  (1–13)
Closure 4  ± 2.878  5.375 ± 3.02  7.25 ± 3.327  4.25 ± 3.732
 (1–9)  (1–8)  (3–13)  (1–12)
Abbreviations: SD, standard deviation; TVPS, Test of Visual Perceptual Skills.Neuropsychiatric Disease and Treatment 2007:3(6) 953
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borderline intelligence at the initial evaluation. IQ testing may 
not be reliable in untreated children with ADHD because of 
inattention and it is often underestimated; moreover, it has 
been shown that visual perception impairment and intelligence 
impairment may coexist as two separate and irreducible deﬁ  -
cits (Stiers 1999). For these reasons we did not exclude these 
children from the study.
The importance for a consensus on the processes that are 
necessary in monitoring children with ADHD after a treat-
ment plan has been established, has been previously stressed 
(Foy and Earls 2005). The TVPS was chosen as an outcome 
measure because it is brief and easy to administer, important 
factors when assessing children with ADHD. It is frequently 
utilized by occupational therapists to monitor the progress 
of children involved in training. The test-retest reliability 
of the total TVPS scores has been demonstrated in learning 
disabled children (McFall et al 1993; Burtner et al 2002) and 
in Chinese preschoolers (Chan and Chow 2005). In contrast, 
the test-retest reliability estimates scores on the subtests were 
low and should be used with extreme caution. In the present 
study the TVPS was useful in measuring the progress of 
children with ADHD following a treatment program.
How can we explain the improvement of visual perceptual 
skills when applying techniques that enhance attention? Atten-
tion has a critical role in information processing. Its adequate 
functioning is required for the development of cognitive abili-
ties including the complex ones involved in scholastic progress. 
As a result, children with attention deﬁ  cits often have difﬁ  cul-
ties in reading, writing, and arithmetic. Attention comprises 
different processes and is fundamentally involved in various 
cognitive functions. According to Posner and Petersen (1990), 
attention encompasses the following subsystems: orientation 
to sensory stimuli, ﬁ  ltering and selection of inputs, and main-
tenance of the thought on a stimulus, mental activity, or goal. 
Impaired attention hinders information processing at multiple 
levels and has been used as an explanation for the functional 
decline that occurs in aging and dementia. Impairments of 
attention in early dementia may contribute to performance 
reductions in other cognitive domains, including memory 
and executive functions (Rizzo 2000). It is possible therefore 
that improvements in the tested visual perceptual skills were 
the by-product of the enhanced attentional processing skills 
that was accomplished through this treatment schedule. We did 
not however document a signiﬁ  cant effect of methylphenidate 
even though medicated children scored higher in the second 
measurement (Table 2). Methylphenidate improves vigilance 
performance, short-term memory performance, and visual 
problem solving (Swanson et al 1993). There is short-term 
beneﬁ  t of stimulants regarding increased concentration and 
improving on-task behavior, whereas the long-term studies 
are difﬁ  cult to evaluate because of methodological problems 
(Douglas et al 1988). In one study the longer term stimulant-
treated group had better executive function performance 
(Vance et al 2003). Nevertheless, stimulants and other medi-
cations are unable to completely ameliorate all the difﬁ  culties 
for all children with ADHD. Therefore, attention needs to be 
directed toward psycho-educational interventions and their 
ability to increase the successful functioning of children with 
ADHD (Hoffman and DuPaul 2000). The deﬁ  cit in working 
memory in children with ADHD can be improved by train-
ing; this also improved response inhibition and reasoning and 
resulted in a reduction of the parent-rated inattentive symptoms 
of ADHD (Klingberg 2005).
Conclusion
Visual perceptual skills improved in children enrolled in 
individualized psycho-educational intervention, irrespective 
of stimulants. The effect of the stimulants could have been 
investigated if the same children had been examined serially, 
after psycho-educational training, before and after methyl-
phenidate administration. A larger sample of patients and a 
carefully executed design is important for this purpose.
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